C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2004
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818642 Benzylaminopyrimidines
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818631 4-fluoroalkyl substituent; agriculture, horticulture; plant disease control
11/16/2004	US6818262 Squarylium dyes
11/16/2004	US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096793A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
11/11/2004	WO2004096792A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096777A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096226A1 Quinazoline derivatives and their use in the treatment of cancer
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004096128A2 Hiv integrase inhibitors
11/11/2004	WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004074244A3 Pyrimidine compounds
11/11/2004	WO2004066997A3 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
11/11/2004	WO2004043337A3 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040225059 Imide-extended liquid bismaleimide resin
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224998 Losartan potassium synthesis
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224973 Substituted indoles as alpha-1 agonists
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224957 Melanocortin receptor-specific compounds
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2523561A1 Substituted 1,4-diazepines and uses thereof
11/11/2004	CA2523102A1 Substituted indoline and indole derivatives
11/11/2004	CA2523020A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474420A1 Quinazoline compounds
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474418A1 Substituted 4-hetaryl-pyrazolines as pest control agents
11/10/2004	EP1474417A2 Processes for preparing losartan and losartan potassium
11/10/2004	EP1474416A1 Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474136A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474135A1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives
11/10/2004	EP0800831B9 Diagnostic marker
11/10/2004	CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/04/2004	WO2004094410A1 Chemical compounds
11/04/2004	WO2004094408A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094395A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/04/2004	WO2004094389A1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094376A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	WO2004093912A1 Preventive and/or therapeutic agent for neutrophil inflammation disease
11/04/2004	WO2004093880A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	WO2004093873A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	WO2004093829A2 (-)1-(4-sulfamylaryl)-3-substituted-5-heteroaryl-2 pyrazolines as inhibitors of cyclooxygenase-2
11/04/2004	WO2004093817A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/04/2004	WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004	WO2004072062A3 Indolylmaleimide derivatives
11/04/2004	WO2004071454A3 Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
11/04/2004	WO2004069794A3 New arylpiperazinyl compounds
11/04/2004	WO2004062613A3 Hiv integrase inhibitors
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2004037797A3 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/04/2004	WO2004004657A3 Hiv integrase inhibitors
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220248 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/04/2004	US20040220247 N-[4-(4,5-Dihydro-1H-imidazol-2-yl-amino)-benzyl]-4-methoxy-benzamide and derivatives; prostaglandin inhibitors; urinary tract disease, disease related pain, neuropathic pain, respiratory asthma, allergy
11/04/2004	US20040220246 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
11/04/2004	US20040220245 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220201 Tyrosine kinase inhibitors
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004	US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004	US20040220177 Anticancer agents

1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 626